0 items
Your cart is empty.
99.2% On-Time Delivery
Tracked International Shipping
Refund Within 28 Days
Secure, Encrypted Checkout
Each peptide batch is tested and verified to meet or exceed 98–99% purity (HPLC).
Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light.
99.2% On-Time Delivery
Tracked International Shipping
Refund Within 28 Days
Secure, Encrypted Checkout
$175.00
This product is available by prescription only
This product does not require a prescription
Out Of Stock
Each peptide batch is tested and verified to meet or exceed 98–99% purity (HPLC).
Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light.
The product is delivered in powdered (lyophilized) form and must be properly reconstituted prior to research use.
Bronchogen (50mg) is manufactured under strict research-grade standards. Peptide purity refers to the proportion of the intended molecular structure present in each batch. Purity verification ensures that every unit meets laboratory specifications.
Structural consistency allows reproducible outcomes in laboratory experiments. Each Bronchogen (50mg) batch is closely monitored to ensure predictable peptide behavior, supporting reliable research workflows.
Bronchogen (50mg) is provided in standardized units. Pack size and labeling support documentation and organization within research peptide supply systems. This facilitates integration into structured laboratory studies.
Bronchogen (50mg) is of interest to researchers due to its tissue-specific peptide fragments. Peptides are short chains of amino acids, which are organic molecules forming proteins.
Laboratories investigate peptide fragments to understand their biochemical properties under controlled settings. Bronchogen (50mg) is strictly intended for research use only, with no clinical claims or therapeutic applications.
Bronchogen (50mg) is investigated in research settings for structural and biochemical studies. “Investigated in research settings” indicates controlled laboratory experimentation without implying benefits or outcomes.
Research may focus on peptide interactions, stability, or analytical evaluation. The neutral positioning ensures studies remain scientific and non-clinical.
Bronchogen (50mg) is intended for laboratory handling only. Standard safety procedures should be followed during all research activities.
Store Bronchogen (50mg) in a cool, dry environment to maintain structural integrity. Proper storage ensures consistent results across research batches.
This peptide is not a prescription product, and it is not suitable for human or veterinary use.
Every batch undergoes quality control testing to verify peptide purity. High-performance liquid chromatography (HPLC) separates molecular components to confirm the intended structure.
Batch consistency is verified to ensure reproducibility in research. Quality control testing Bronchogen (50mg) maintains research-grade standards and traceable documentation.
Units are labeled with batch numbers, pack size, and analytical records, supporting laboratory workflows and peptide research supply management.
Bronchogen (50mg) consists of a synthetic peptide fragment. Peptides are short chains of amino acids, which are the building blocks of proteins.
Analytical techniques, such as mass spectrometry, confirm the molecular structure of Bronchogen (50mg). These methods verify molecular weight and purity for research-grade accuracy.
No sugars or additional excipients are included, maintaining consistent peptide purity for laboratory experiments.
Novera Research delivers high-quality research peptides developed under strict manufacturing and quality-control standards. Each product is carefully synthesized, tested, and handled to ensure consistency, reliability, and transparency for advanced research applications.
High-purity, research-grade peptide synthesis
Analytical testing to verify quality and composition
Consistent batch-to-batch performance
Batch identification on every vial for traceability
Stored and shipped under controlled conditions
Research-grade dual-peptide blend combining short-acting synthetic peptides for flexible laboratory research protocols.
Research-grade dual GIP/GLP-1 peptide by NOVERA, USA-made, 99% purity, for advanced metabolic studies.
Research-grade synthetic tetrapeptide formulated for experimental cellular and longevity-focused research in controlled laboratory environments.
Research-grade synthetic peptide analog formulated for experimental metabolic pathway research in controlled laboratory environments.
Research-grade synthetic dual-peptide formulation combining amylin analog and GLP-1 receptor agonist for dual-mechanism pathway studies and combination peptide research in controlled laboratory environments.
